Alx Oncology Holdings (ALXO) Debt to Equity (2019 - 2026)
Alx Oncology Holdings recorded quarterly Debt to Equity of $0.06 in Q1 2026, down 85.01% quarter-over-quarter from $0.38 in Q4 2025, and down 50.2% year-over-year from $0.11 in Q1 2025.
Alx Oncology Holdings' Debt to Equity history runs 8 years deep, the most recent figure standing at $0.06 for Q1 2026.
- In Q1 2026, Debt to Equity fell 50.2% year-over-year to $0.06; the TTM figure through Mar 2026 stood at $0.06 (down 50.2% YoY), while the FY2025 annual figure was $0.38, up 330.47% from the prior year.
- Debt to Equity came in at $0.06 for Q1 2026 at Alx Oncology Holdings, down from $0.38 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.38 in Q4 2025 to a low of $0.02 in Q2 2022.
- A 5-year average of $0.09 and a median of $0.06 in 2023 frame the typical range for Debt to Equity.
- Across the five-year window, Debt to Equity soared 402.03% in 2022 and tumbled 50.2% in 2026, its largest moves.
- Alx Oncology Holdings' Debt to Equity stood at $0.04 in 2022, then gained by 21.26% to $0.05 in 2023, then jumped by 71.56% to $0.09 in 2024, then jumped by 330.47% to $0.38 in 2025, then sank by 85.01% to $0.06 in 2026.
- According to Business Quant data, Debt to Equity over the past three periods registered $0.06, $0.38, and $0.23 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | 0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.23 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.05 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2020 | 0.02 |
| Jun 30, 2020 | -0.07 |
| Dec 31, 2019 | -0.08 |